Inhibition of Histone Acetylation as a Tool in Bone Tissue Engineering
- 1 October 2006
- journal article
- research article
- Published by Mary Ann Liebert Inc in Tissue Engineering
- Vol. 12 (10), 2927-2937
- https://doi.org/10.1089/ten.2006.12.2927
Abstract
Our approach to bone tissue engineering is the in vitro expansion and osteogenic differentiation of bone marrow–derived human mesenchymal stem cells (hMSCs) and their subsequent implantation on porous ceramic materials. Current osteogenic differentiation protocols use dexamethasone to initiate the osteogenic process, thus ignoring the multiple signaling pathways that control osteogenesis in vivo. Supporting osteogenesis at multiple stages might further enhance the bone-forming capacity of hMSCs. As reported previously, inhibition of so-called histone deacetylases (HDACs) stimulates osteoblast maturation, and in this report, we investigated whether trichostatin A (TSA), a widely used HDAC inhibitor, can be implemented in bone tissue engineering. We confirmed that TSA treatment of hMSCs results in increased expression of alkaline phosphatase (ALP) with concomitant increase in mineralization. Flow cytometry demonstrated that TSA increases the percentage of ALP-positive hMSCs as well as their average ALP expression level, but the robustness of the response differs between donors. Unfortunately, TSA has a profound negative effect on cell proliferation, so we investigated whether hMSCs respond to TSA after reaching confluence. Confluent hMSCs on tissue culture plastic displayed enhanced ALP expression. Therefore, we seeded TSA-treated hMSCs onto ceramic particles and analyzed ectopic bone formation upon implantation in immune-deficient mice. Unfortunately, TSA-treated hMSCs did not display better bone formation in vivo than control cells. Finally, we observed that TSA treatment strongly enhanced bone formation of ex vivo cultured mouse calvaria, which warrants further exploration of TSA in bone tissue engineering.Keywords
This publication has 41 references indexed in Scilit:
- Histone Deacetylase Inhibitors Promote Osteoblast MaturationJournal of Bone and Mineral Research, 2005
- Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle DegenerationScience, 2005
- Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical ImplicationMolecular and Cellular Biology, 2005
- Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3β-dependent and -independent MannerPublished by Elsevier BV ,2005
- Histone Deacetylase 3 Interacts with Runx2 to Repress the Osteocalcin Promoter and Regulate Osteoblast DifferentiationJournal of Biological Chemistry, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Histone Acetylation Influences Thyroid Hormone and Retinoic Acid-Mediated Gene ExpressionDNA and Cell Biology, 1997
- Characterization of cells with osteogenic potential from human marrowBone, 1992
- Regulation of alkaline phosphatase and alpha2(I) procollagen synthesis during early intramembranous bone formation in the rat mandibleDifferentiation, 1990
- Characterization of the rat osteocalcin gene: stimulation of promoter activity by 1,25-dihydroxyvitamin D3Biochemistry, 1988